TY  - JOUR 
T1  - Sex-disparate safety profile of Obinutuzumab: a pharmacovigilance analysis using the FDA adverse event reporting system
JO  - Clinics
A1  - Bai, Zhixun
A1  - Chen, Jiaxi
A1  - Lan, Yongping
A1  - Li, Houze
A1  - Zheng, Rubin
A1  - Deng, Miao
A1  - Pang, Wenyi
SN  - 1807-5932
UL  - 10.1016/j.clinsp.2026.100865
VL  - 81 
Y1  - 2026
PB  - Brasil 
ER  -